Stock Groups

RenovoRx Stock Soars 70% After Therapeutic Platform Presentation -Breaking

by Mike Robinson

[ad_1]

© Reuters.

Sam Boughedda

Investing.com — A biopharmaceutical firm RenovoRx Inc stock rose over 70% Wednesday following Tuesday’s presentation by RenovoTAMP, Inc on therapeutics.

RenovoRx shares hit a record high of $12.50 during the earlier session. However, they currently trade at around $9. 20.

According to Dr. Ripal, the presenter, “RenovoTAMP is designed to minimize arterial microvasculature during drug delivery, and enhance drug delivery directly into the tumor.”

It was presented at the Miami Cancer Institutes New Advances in the Management of Pancreatic Cancer CME. The presentation included preliminary clinical results of the platform, radiation therapy, and benefits for patients suffering from stage 3 localized advanced pancreatic carcinoma.

The data was also taken from the phase 3 company study, which included five patients. 

Dr. Ghandi said, “This platform allows the targeted treatment for inoperable LAPC with reduced side effects typical systemic chemotherapy. While shifting the focus on what’s most important to our patient: Improving quality of life and allowing us to spend more time spending with loved ones, this is an innovative therapy platform.” 

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses or other consequences arising from the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is the most risky investment form. Please make sure you are fully aware of all the costs and risks involved.



[ad_2]